Kellee Parker
No Rating Available
(Learn About Our Rating System)

Kellee Parker, DO, MCR

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-1000
Get Directions

Dr. Parker received her medical degree from Rocky Vista University, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Health & Science University. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Health & Science University.

Dr. Parker is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children’s Hospital.

Dr. Parker’s clinical interests include care of children with leukemia, lymphoma and various other childhood cancers. She is also interested in the long-term care of patients that have survived childhood cancer. Her research interests include improved care for childhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

Specialties

Board Certification

American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

Dr. Parker received her medical degree from Rocky Vista University, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Health & Science University. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Health & Science University.

Dr. Parker is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children’s Hospital.

Dr. Parker’s clinical interests include care of children with leukemia, lymphoma and various other childhood cancers. She is also interested in the long-term care of patients that have survived childhood cancer. Her research interests include improved care for childhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Hematology/Oncology
Board Certification
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

Education history

Undergraduate University of Oregon B.S.
Professional Medical Osteopathic Medicine - Rocky Vista University College of Osteopathic Medicine D.O.
Residency Pediatrics - Oregon Health & Science University Resident
Fellowship Pediatric Hematology/Oncology - Oregon Health & Science University Fellow
Graduate Training Basic Certificate in Quality & Safety - Institute for Healthcare Improvement Certification
Graduate Training Oregon Health & Science University M.C.R.
Graduate Training Health Experiences Research Training - University of New Mexico Certificate

Selected Publications

Journal Article

  1. Parker K, Cottrell E, Stork L, Lindemulder S (2021). Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932. Pediatr Blood Cancer.
  2. Christensen V, Parker K, Cottrell (2021). Leveraging a qualitative data repository to integrate patient and caregiver perspectives into clinical research. Journal of clinical and translational science, 5(1), e155.
  3. Parker K, Durben N, Oleson D, Yu Y, Lim J, Recht M, Lindemulder (2023). Hopping As an Indicator of Chemotoxicity: Gait Analysis in Patients with Leukemia and Lymphoma. Journal of Pediatric Hematology/Oncology, 45,
  4. Christensen V, Parker K, Chan K, Saxton L, Cottrell (2022). ‘Never once was I thinking the c¿word’: Parent perspectives on the facilitators and barriers to getting a childhood cancer diagnosis. Journal of clinical nursing,
  5. Ou JL, Bennion N, Parker KN, Fair D, Hanson HA, Kepka DL, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff A (2023). Risk factors for HPV-associated subsequent malignant neoplasms among adolescent and young adult survivors . Cancer epidemiology, biomarkers & prevention, 32(5), 625-633.
  6. Parker K, Christensen V, Lindemulder S, Chan L, Saxton L, Cottrell (2023). Family Perspectives on the Transition from Active Treatment to Survivorship for Children with Cancer. Pediatric blood & cancer,
  7. D. Beeler, V. Christensen, K. Parker and E. Cottrel (2023). "The place it puts us in emotionally and relationally with our child, it's damaging": understanding the real world psychosocial needs of caregivers and childhood cancer survivors . Journal of cancer survivorship,
  8. Christensen V, Varnum M, Parker K, Chan LHK, Saxton L, Cottrell (2024). The Impact of Structural and Meso-Level Factors on Caregiver Coping Abilities When Supporting a Child with Cancer: A Qualitative Study. International journal of environmental research and public health, 21(7),
  9. Parker KN, Alexander SW, Jacola LM, Buff KA, Hwang K, Hashemi E, Stoddard GJ, Jibb L (2025). Characterizing Difficulty and Life Disruption During B-Acute Lymphoblastic Leukemia Therapy From the Perspective of Parents: A Survey Study. Pediatric blood & cancer, e32041.

Letter

  1. Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA, Chang BH (2019). Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. [Letter to the editor]. Br J Haematol, 186(2), 333-336.